In the present study, we evaluated MR120 and MR452 in a direct comparative analysis using T cell adoptive transfer colitis, which to our knowledge has not previously been applied to CCL20/CCR6 modulators, with the aim of complementing data from previous chemical models and obtaining a more comprehensive view of how different in vivo models respond to this drug class [23]. The gene discussed is CCL20; the disease is colitis.